Boston biotech Ginkgo Bioworks has raised $265m in a round that gives the firm, incubated at and backed by the Y Combinator, a value of $1.3bn, according to data from Pitchbook. Ginkgo, which uses microbugs to create perfumes and food, is one of the hottest properties in its field, and was valued at $450m in Earlier this year. June 2016, the company partnered with Bayer to form a new venture that aims to optimise farming and fertiliser, and raised $100m in September.
Boston biotech Ginkgo Bioworks has raised $265m in a round that gives the firm, incubated at and backed by the Y Combinator, a value of $1.3bn, according to data from Pitchbook. Ginkgo, which uses microbugs to create perfumes and food, is one of the hottest properties in its field, and was valued at $450m in June 2016. Earlier this year, the company partnered with Bayer to form a new venture that aims to optimise farming and fertiliser, and raised $100m in September.